Metastatic Cholangiocarcinoma
Also known as: Cholangiocarcinoma Metastatic / Metastatic cholangiocarcinoma (morphologic abnormality) / Intrahepatic bile duct carcinoma / Cholangiosarcoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract (disorder) / Cholangiocarcinoma / Cholangiocarcinoma (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB14568 | Ivosidenib | An isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB14568 | Ivosidenib | Isocitrate dehydrogenase [NADP] cytoplasmic | target |
DB14568 | Ivosidenib | Cytochrome P450 3A4 | enzyme |
DB14568 | Ivosidenib | Cytochrome P450 2B6 | enzyme |
DB14568 | Ivosidenib | Cytochrome P450 2C9 | enzyme |
DB14568 | Ivosidenib | Cytochrome P450 2C8 | enzyme |
DB14568 | Ivosidenib | Solute carrier family 22 member 8 | transporter |
DB14568 | Ivosidenib | P-glycoprotein 1 | transporter |